{
    "organizations": [],
    "uuid": "203f8c44063565e58744e9207f3d41abfb02ca2d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-infant-bacterial-therapeutics-q4-o/brief-infant-bacterial-therapeutics-q4-operating-loss-narrows-to-sek-9-1-mln-idUSFWN1QI0E4",
    "ord_in_thread": 0,
    "title": "BRIEF-Infant Bacterial Therapeutics Q4 Operating Loss Narrows To Sek 9.1 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Infant Bacterial Therapeutics Ab :\n* Q4 NET SALES SEK 0 VERSUS SEK 113,000 YEAR AGO‍​ * Q4 OPERATING LOSS SEK 9.1 MILLION VERSUS LOSS SEK 14.1 MILLION YEAR AGO\n* BOARD PROPOSES NO DIVIDEND FOR FY 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-28T16:10:00.000+02:00",
    "crawled": "2018-03-01T21:22:56.030+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "infant",
        "bacterial",
        "therapeutic",
        "ab",
        "q4",
        "net",
        "sale",
        "sek",
        "versus",
        "sek",
        "year",
        "q4",
        "operating",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "board",
        "proposes",
        "dividend",
        "fy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}